Dr. Juan Garza, MD
What this data tells you about Dr. Garza
Dr. Juan Garza is an interventional cardiology in Harlingen, TX, with 20 years in practice. Based on federal Medicare data, Dr. Garza performed 2,243 Medicare services across 1,582 unique beneficiaries.
Between the years covered by Open Payments, Dr. Garza received a total of $7,954 from 32 pharmaceutical and/or device companies across 238 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Garza is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 613 | $88 | $234 |
| EKG interpretation and report | 318 | $6 | $35 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 186 | $130 | $460 |
| Office visit, established patient (20-29 min) | 162 | $63 | $149 |
| Electrocardiogram (EKG), 12-lead | 147 | $10 | $70 |
| Hospital follow-up visit, moderate complexity | 114 | $61 | $151 |
| Regadenoson injection (Lexiscan) for heart stress test | 64 | $45 | $153 |
| Initial hospital admission, moderate complexity | 59 | $97 | $330 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 43 | $726 | $2,844 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 43 | $38 | $123 |
| Insertion of stent in vein with review by radiologist, initial vein | 35 | $2,627 | $7,722 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 35 | $16 | $70 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 35 | $11 | $150 |
| New patient office visit (45-59 min) | 34 | $119 | $392 |
| Review by radiologist of both arms and legs veins of both arms or legs image | 33 | $102 | $345 |
| Insertion of tube into vein, second order branch | 28 | $375 | $2,209 |
| Echocardiogram, transthoracic | 27 | $144 | $500 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 27 | $8 | $25 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 26 | $134 | $415 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 23 | $20 | $78 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 22 | $631 | $1,685 |
| Ultrasound of both sides of head and neck blood flow | 21 | $29 | $100 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 21 | $17 | $65 |
| Heart muscle strain imaging | 20 | $29 | $97 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 18 | $311 | $939 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 18 | $48 | $285 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 17 | $38 | $85 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 17 | $79 | $408 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 14 | $49 | $125 |
| Office visit, established patient, complex (40-54 min) | 12 | $139 | $343 |
| Ultrasound of leg arteries or artery grafts | 11 | $140 | $425 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Garza is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Garza experienced with office visit, established patient (30-39 min)?
Does Dr. Garza receive payments from pharmaceutical companies?
How do Dr. Garza's costs compare to other interventional cardiologys in Harlingen?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology